BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22595227)

  • 1. Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.
    Lai Y; Yu XP; Zhang Y; Tian Q; Song H; Mucignat MT; Perris R; Samuels J; Krasnokutsky S; Attur M; Greenberg JD; Abramson SB; Di Cesare PE; Liu CJ
    Osteoarthritis Cartilage; 2012 Aug; 20(8):854-62. PubMed ID: 22595227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
    Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
    Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.
    Happonen KE; Saxne T; Aspberg A; Mörgelin M; Heinegård D; Blom AM
    Arthritis Rheum; 2010 Dec; 62(12):3574-83. PubMed ID: 20737467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
    Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
    Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA.
    Vilím V; Vobůrka Z; Vytásek R; Senolt L; Tchetverikov I; Kraus VB; Pavelka K
    Clin Chim Acta; 2003 Feb; 328(1-2):59-69. PubMed ID: 12559599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum.
    Yamanokuchi K; Tagami M; Nishimatsu E; Shimizu Y; Hirose Y; Komatsu K; Misumi K
    Equine Vet J; 2009 Jan; 41(1):41-6. PubMed ID: 19301580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ
    Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
    Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
    Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.
    Arai K; Misumi K; Carter SD; Shinbara S; Fujiki M; Sakamoto H
    Equine Vet J; 2005 Jan; 37(1):31-6. PubMed ID: 15651731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cartilage oligomeric matrix protein forms protein complexes with synovial lubricin via non-covalent and covalent interactions.
    Flowers SA; Kalamajski S; Ali L; Björkman LI; Raj JR; Aspberg A; Karlsson NG; Jin C
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1496-1504. PubMed ID: 28373131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
    Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
    Skoumal M; Kolarz G; Klingler A
    Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein modification by deamidation indicates variations in joint extracellular matrix turnover.
    Catterall JB; Hsueh MF; Stabler TV; McCudden CR; Bolognesi M; Zura R; Jordan JM; Renner JB; Feng S; Kraus VB
    J Biol Chem; 2012 Feb; 287(7):4640-51. PubMed ID: 22179616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Rheumatol Int; 2006 Sep; 26(11):1001-4. PubMed ID: 16485108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin.
    Luan Y; Kong L; Howell DR; Ilalov K; Fajardo M; Bai XH; Di Cesare PE; Goldring MB; Abramson SB; Liu CJ
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1413-20. PubMed ID: 18485748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
    Skiöldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S
    Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.